abstract |
a tumor tumor pharmaceutical composition used in combination therapy of lenvatinib and (6s, 9as) -n-benzyl-8 - ({6- [3- (4-ethylpiperazin-1-yl) azetidin-1- yl] pyridin-2-yl} methyl) -6- (2-fluoro-4-hydroxybenzyl) -4,7-dioxo-2- (prop-2-en-1-yl) hexahydro-2h-pyrazine [ 2,1-c] [1,2,4] triazine-1 (6h) -carboxamide. |